DK255786D0 - Quinazolinderivater eller farmaceutisk acceptable salte eller estere deraf, deres fremstilling og anvendelse som farmaceutika - Google Patents

Quinazolinderivater eller farmaceutisk acceptable salte eller estere deraf, deres fremstilling og anvendelse som farmaceutika

Info

Publication number
DK255786D0
DK255786D0 DK255786A DK255786A DK255786D0 DK 255786 D0 DK255786 D0 DK 255786D0 DK 255786 A DK255786 A DK 255786A DK 255786 A DK255786 A DK 255786A DK 255786 D0 DK255786 D0 DK 255786D0
Authority
DK
Denmark
Prior art keywords
group
heteroatom
quinazoline derivatives
pharmaceuticals
esters
Prior art date
Application number
DK255786A
Other languages
English (en)
Other versions
DK255786A (da
Inventor
Ann Lesley Jackman
David Richard Newell
Terence Richard Jones
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of DK255786D0 publication Critical patent/DK255786D0/da
Publication of DK255786A publication Critical patent/DK255786A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK255786A 1985-05-31 1986-05-30 Quinazolinderivater eller farmaceutisk acceptable salte eller estere deraf, deres fremstilling og anvendelse som farmaceutika DK255786A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858513754A GB8513754D0 (en) 1985-05-31 1985-05-31 Anti-cancer quinazoline derivatives

Publications (2)

Publication Number Publication Date
DK255786D0 true DK255786D0 (da) 1986-05-30
DK255786A DK255786A (da) 1986-12-01

Family

ID=10579966

Family Applications (1)

Application Number Title Priority Date Filing Date
DK255786A DK255786A (da) 1985-05-31 1986-05-30 Quinazolinderivater eller farmaceutisk acceptable salte eller estere deraf, deres fremstilling og anvendelse som farmaceutika

Country Status (17)

Country Link
US (1) US5236927A (da)
EP (1) EP0204529B1 (da)
JP (1) JPS61282368A (da)
AT (1) ATE87621T1 (da)
AU (1) AU592271B2 (da)
DE (1) DE3688150T2 (da)
DK (1) DK255786A (da)
ES (1) ES8800911A1 (da)
FI (1) FI862303A (da)
GB (2) GB8513754D0 (da)
GR (1) GR861418B (da)
HU (1) HUT45512A (da)
IL (1) IL78910A0 (da)
NO (1) NO862170L (da)
NZ (1) NZ216363A (da)
PT (1) PT82682B (da)
ZA (1) ZA864051B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4857530A (en) * 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
GB8809978D0 (en) * 1988-04-27 1988-06-02 Ici Plc Anti-tumour agents
EP0365763A1 (en) * 1988-09-30 1990-05-02 Agouron Pharmaceuticals, Inc. Antiproliferative cyclic compounds
US5286726A (en) * 1990-04-12 1994-02-15 The Regents Of The University Of Michigan Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
US6762188B1 (en) 1990-06-19 2004-07-13 Smithkline Beecham Corporation Pharmaceutically active benzoquinazoline compounds
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
GB9105771D0 (en) * 1991-03-19 1991-05-01 Cancer Res Inst Royal Anti-cancer compounds
GB9205320D0 (en) * 1992-03-11 1992-04-22 Ici Plc Anti-tumour compounds
GB9205907D0 (en) * 1992-03-18 1992-04-29 Cancer Res Inst Royal Anti-cancer compounds
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
US7262058B2 (en) * 2001-03-09 2007-08-28 Nonda Katopodis Method for determining lipid associated sialoprotein in body fluids
BR0315403A (pt) * 2002-10-18 2005-08-16 Koninkl Philips Electronics Nv Método, sistema, e dispositivo de assinatura para prover autenticação de integridade de dados e proteção de dados, dispositivo de verificação para verificar autenticação de integridade de dados e proteção de dados, sinal compreendendo fragmentos de dados, e, produto de programa de computador
WO2004041755A2 (en) * 2002-11-04 2004-05-21 Nps Pharmaceuticals, Inc. Quinazolinone compounds as calcilytics
EP1924568A1 (en) * 2005-07-15 2008-05-28 Schering Corporation Quinazoline derivatives useful in cancer treatment
US20070015774A1 (en) * 2005-07-15 2007-01-18 Schering Corporation Quinazoline derivatives useful in cancer treatment
KR101129868B1 (ko) 2006-10-04 2012-04-12 화이자 프로덕츠 인코포레이티드 칼슘 수용체 길항제로서의 피리도［4,3-ｄ］피리미딘-4(3Ｈ)-온 유도체
EP2220050A2 (en) 2007-10-26 2010-08-25 The Regents Of The University Of California Diarylhydantoin compounds as androgen receptor modulators
US8431576B2 (en) 2009-06-25 2013-04-30 Alkermes Pharma Ireland Limited Heterocyclic compounds for the treatment of neurological and psychological disorders
WO2011084846A1 (en) * 2010-01-07 2011-07-14 Alkermes, Inc. Quaternary ammonium salt prodrugs
US8592427B2 (en) 2010-06-24 2013-11-26 Alkermes Pharma Ireland Limited Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
IL296695A (en) 2011-03-18 2022-11-01 Alkermes Pharma Ireland Ltd Pharmaceutical preparations containing sorbitan esters
JP6333802B2 (ja) 2012-03-19 2018-05-30 アルカームス ファーマ アイルランド リミテッド ベンジルアルコールを含む医薬組成物
WO2013142198A1 (en) 2012-03-19 2013-09-26 Alkermes Pharma Ireland Limited Pharmaaceutical compositions comprising fatty acid esters
CA2867123C (en) 2012-03-19 2021-02-16 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising water-insoluble antipsychotic agents and glycerol esters
NZ730571A (en) 2012-09-19 2018-12-21 Alkermes Pharma Ireland Ltd Pharmaceutical compositions having improved storage stability
EP3119399A4 (en) 2014-03-20 2017-09-27 Alkermes Pharma Ireland Limited Aripiprazole formulations having increased injection speeds
US11273158B2 (en) 2018-03-05 2022-03-15 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
WO2024028999A1 (ja) * 2022-08-03 2024-02-08 Ils株式会社 Ｎ－［４－メチルアミノベンゾイル］－ｌ－グルタミン酸ジエチルエステルの製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1021196A (en) * 1964-02-20 1966-03-02 Parke Davis & Co Novel amino acids and means for producing the same
US3471498A (en) * 1967-08-11 1969-10-07 Parke Davis & Co Certain n-p-((2,4-diamino-6-quinazolinyl)-methyl)benzoylamino acids
GB2065653B (en) * 1979-12-19 1983-03-09 Nat Res Dev Anti-cancer quinazoline derivatives
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents

Also Published As

Publication number Publication date
GB2175903A (en) 1986-12-10
US5236927A (en) 1993-08-17
ZA864051B (en) 1987-01-28
HUT45512A (en) 1988-07-28
ES8800911A1 (es) 1987-12-01
NO862170L (no) 1986-12-01
FI862303A0 (fi) 1986-05-30
AU592271B2 (en) 1990-01-04
FI862303A (fi) 1986-12-01
PT82682B (pt) 1988-03-03
DE3688150T2 (de) 1993-07-29
GR861418B (en) 1986-09-26
ATE87621T1 (de) 1993-04-15
EP0204529B1 (en) 1993-03-31
GB8513754D0 (en) 1985-07-03
JPS61282368A (ja) 1986-12-12
ES555548A0 (es) 1987-12-01
DK255786A (da) 1986-12-01
AU5822086A (en) 1986-12-04
GB2175903B (en) 1988-10-12
EP0204529A2 (en) 1986-12-10
IL78910A0 (en) 1986-09-30
EP0204529A3 (en) 1987-11-19
PT82682A (en) 1986-06-01
GB8613184D0 (en) 1986-07-02
DE3688150D1 (de) 1993-05-06
NZ216363A (en) 1989-07-27

Similar Documents

Publication Publication Date Title
DK255786A (da) Quinazolinderivater eller farmaceutisk acceptable salte eller estere deraf, deres fremstilling og anvendelse som farmaceutika
ES8308314A1 (es) Procedimiento para preparar derivados de 2-amino-4-hidroxiquinazolina.
DK114783A (da) Hidtil ukendte forbindelser, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK345989A (da) Quinolinderivater
PT83647B (pt) Processo para a preparacao de novos derivados de benzimidazole com actividade farmacologica e de composicoes farmaceuticas que os contem
DK37189A (da) Substituerede quinoliner og cinnoliner, fremgangsmaader til deres fremstilling samt deres anvendelse
AR241422A1 (es) Procedimiento para la preparacion de derivados de difenil(metil-etil-0 etenil) piperidinas.
DK529585A (da) N-(6-methoxy-5-(perflouralkyl)-1-naphtholyl)-n-methylglyciner og deres thionaphthoyl analoge, deres fremstilling og anvendelse som laegemidler
ES2068497T3 (es) Derivados de urea, su produccion, y composiciones farmaceuticas que los contienen.
PT89757A (pt) Processo para a preparacao de novos derivados da xantina e de composicoes farmaceuticas que os contem, uteis no tratamento da ulcera peptica
NO891381L (no) Fremgangsmaate for fremstilling av nye fluorfosfonatnukleotidderivater.
PT83975B (pt) Processo para a preparacao de derivados de 5-aminoalquil-beta-carbolinas e de composicoes farmaceuticas que os contem
DK614989A (da) Indolderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
ATE144900T1 (de) Verwendung von xanthinderivaten gegen magengeschwüre
ATE87307T1 (de) Isoindolinderivate und verfahren zu ihrer herstellung.
ES2045335T3 (es) Un procedimiento para la preparacion de nuevas s-difluorometilhomocisteinas.
ES2039270T3 (es) Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment